Apollo Hospitals share price: Q4 profit up 35.86% FY26

Stock snapshot on July 6, 2026

Apollo Hospitals Enterprise Ltd. (NSE: APOLLOHOSP, BSE: 508869) traded marginally lower on July 6, 2026, with multiple market snapshots showing the stock near the Rs 8,890 level. At 15:47:24 PM IST, the share price was reported at Rs 8,892.30, down 0.06% from the previous close. Another snapshot around 10:17:24 AM showed the same price of Rs 8,892.30, also 0.06% lower than the prior close of Rs 8,897.35. A separate end-of-day style update showed Rs 8,888.50, down Rs 5.00 (0.06%). The intraday move was small, but it came with a fresh set of fundamental data points around FY26 earnings.

How the price moved during the session

Data feeds cited a tight trading band during the day. One range quoted for the session was Rs 8,822.15 to Rs 8,927.00. Another update listed the day’s low at Rs 8,823.50 and the day’s high at Rs 8,925.00. In other words, the stock hovered close to its reported highs even though it finished slightly below the prior close in some snapshots. The reported previous close also differed across snippets, including Rs 8,893.50 and Rs 8,897.35, indicating updates were captured at different times or from different market sources. Still, the direction was consistent: the stock was largely flat on the day.

Recent returns: 5-day and year-to-date

Apollo Hospitals was shown delivering strong gains in 2026 so far, even as the daily move on July 6 looked muted. One update said the stock has returned 26.28% in the current year and 3.51% over the last five days. A separate market table showed a 5-day change of +3.06% and a “1st Jan change” of +26.65%. The broad picture across these numbers is similar: short-term gains over the past week and a strong year-to-date rise.

Market capitalisation and company classification

At 10:17:24 AM on July 6, 2026, the market capitalisation of Apollo Hospitals Enterprise was listed as Rs 1,27,857.63 crore. Another entry placed market capitalisation at Rs 1,27,874.88470295 crore, based on the latest share price used in that calculation. The stock was also labelled as a large-cap name. The company was tagged under the Healthcare sector and the Hospital & Healthcare Services industry.

52-week range and what it signals

The reported 52-week range for Apollo Hospitals Enterprise was Rs 6,696.50 to Rs 8,925.00. With the share price quoted close to Rs 8,888 to Rs 8,892 on July 6, the stock was trading near the top end of this band. That matters for investors because it frames the day’s move as a pause near recent highs rather than a reversal after a run-up. The same data set that listed the day’s low and high also showed a small “upside” of 0.41% versus a “downside” of 0.73% from the reference price used in that snapshot.

Earnings cue: Q4 FY26 profit growth

A key fundamental update in the data was the Q4 FY25-26 result headline: Apollo Hospitals Enterprise Ltd.’s net profit rose 35.86% year-on-year to Rs 529.30 crore in Q4 2025-2026. The snippet did not provide revenue, margins, or segment-level performance, but the profit growth figure stands out because it reinforces the company’s earnings momentum during a period when the stock is already near its 52-week high. The market reaction on July 6, however, was not a sharp move, suggesting the day’s trading was more range-bound than event-driven.

Business profile: integrated healthcare model

Apollo Hospitals Enterprise Limited is described as an integrated healthcare company. It is engaged in providing hospital services and selling pharma and wellness products through a network of pharmacies. Its operations include multidisciplinary private hospitals, clinics, diagnostic centres, and pharmacies. This integrated model typically links hospital footfalls, diagnostics, and pharmacy purchases within a single brand ecosystem, though the provided data does not quantify contributions by segment.

Analyst targets and market signals in the feed

The input data included several references to analyst expectations and technical indicators. One consensus set showed an average 12-month price target of Rs 9,285.81, with a high estimate of Rs 9,979 and a low estimate of Rs 6,230. Another platform’s range was quoted as a max estimate of Rs 9,400 and a min estimate of Rs 5,700. A separate line referenced “Mean Recos by 26 Analysts” with a “Buy” stance and a target of Rs 7,500. The same feed also listed volatility at 0.93% and a beta coefficient of 1.22, along with a “buy” technical rating for the day and for the 1-week view.

Key numbers at a glance

Why the July 6 move matters for investors

The July 6 trading action shows Apollo Hospitals consolidating near the top of its 52-week band while remaining close to the prior close. That combination often attracts attention because it suggests the market is weighing fresh information without forcing a large repricing in a single session. The strongest hard datapoint in the provided information is the Q4 net profit growth to Rs 529.30 crore, up 35.86% year-on-year. In parallel, the stock’s year-to-date return was shown around 26%, which helps explain why daily volatility was limited despite the earnings headline.

Conclusion

Apollo Hospitals Enterprise traded almost flat around Rs 8,890 on July 6, 2026, within an intraday band reported near Rs 8,823 to Rs 8,925, and close to a stated 52-week high of Rs 8,925. The company’s Q4 FY26 net profit of Rs 529.30 crore, up 35.86% year-on-year, remains the key fundamental marker referenced alongside the price action. Market participants will likely keep tracking subsequent earnings updates and any changes in published target prices as new data points emerge.